Significance of expression of cardiotrophin-1 in remodeled myocardium after acute myocardial infarction in rats
BU Congya
Abstract
BU Congya
Abstract
Objective: To study the dynamic changes of cardiotrophin-1(CT-1),mRNA expression in non-infarction zone in left ventricle (LVNIZ) and the relationship between the changes and left ventricular remodeling (LVRM) in rats with AMI, also to evaluate the effect of losartan on CT-1 expression. Method:The 73 surviving acute myocardial infarction(AMI) male Wistar rats were randomly divided into 2 groups at 24 hours after MI: AMI group and losartan treatment group. The former was subdivided into 6 groups according to different time at 1st, 3 rd, 7 th, 14 th, 21 st, 28 th day after AMI. Losartan was delivered by direct gastric gavage (20 mg·kg -1·d -1) for 4 weeks beginning at 2nd after AMI. Sham-operated and normal rats were selected randomly to serve as non-infarcted controls. There are 8 rats in each group. Myocardial AngⅡand collagen contents(HC) were measured by radioimmunoassay and chloramine T method respectively in LVNIZ. CT-1 mRNA expression in LVNIZ was determined by RT-PCR. Result:①Compared with sham-operated rats and control rats, both myocardial AngⅡand HC in LVNIZ were markedly increased (P 0.05~ 0.001) in AMI groups and positively related to LVRM (all P 0.01); ②The expression of CT-1 mRNA in LVNIZ gradually increased as early as 1 day after MI, peaked at 14 day and declined thereafter, but remained higher than those in sham-operated rats (P 0.05~ 0.01); ③Correlation analysis found that there were significant positive correlations among CT-1 mRNA level、myocardial AngⅡ、HC and LVRM (P 0.05~ 0.01);④Myocardial AngⅡ、HC and CT-1 mRNA were all decreased in losartan-treated group with depressed LVRM compared with 28 days after MI group(P 0.05). Conclusion:Overexpression of CT-1 mRNA in LVNIZ may play an important role in LVRM after MI. The mechanisms of losartan in preventing LVRM may be partly through depressing CT-1 transcripition, which is worth studying further.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the dynamic changes of cardiotrophin-1(CT-1),mRNA expression in non-infarction zone in left ventricle (LVNIZ) and the relationship between the changes and left ventricular remodeling (LVRM) in rats with AMI, also to evaluate the effect of losartan on CT-1 expression. Method:The 73 surviving acute myocardial infarction(AMI) male Wistar rats were randomly divided into 2 groups at 24 hours after MI: AMI group and losartan treatment group. The former was subdivided into 6 groups according to different time at 1st, 3 rd, 7 th, 14 th, 21 st, 28 th day after AMI. Losartan was delivered by direct gastric gavage (20 mg·kg -1·d -1) for 4 weeks beginning at 2nd after AMI. Sham-operated and normal rats were selected randomly to serve as non-infarcted controls. There are 8 rats in each group. Myocardial AngⅡand collagen contents(HC) were measured by radioimmunoassay and chloramine T method respectively in LVNIZ. CT-1 mRNA expression in LVNIZ was determined by RT-PCR. Result:①Compared with sham-operated rats and control rats, both myocardial AngⅡand HC in LVNIZ were markedly increased (P 0.05~ 0.001) in AMI groups and positively related to LVRM (all P 0.01); ②The expression of CT-1 mRNA in LVNIZ gradually increased as early as 1 day after MI, peaked at 14 day and declined thereafter, but remained higher than those in sham-operated rats (P 0.05~ 0.01); ③Correlation analysis found that there were significant positive correlations among CT-1 mRNA level、myocardial AngⅡ、HC and LVRM (P 0.05~ 0.01);④Myocardial AngⅡ、HC and CT-1 mRNA were all decreased in losartan-treated group with depressed LVRM compared with 28 days after MI group(P 0.05). Conclusion:Overexpression of CT-1 mRNA in LVNIZ may play an important role in LVRM after MI. The mechanisms of losartan in preventing LVRM may be partly through depressing CT-1 transcripition, which is worth studying further.
Key concepts: Medicine, Losartan, Myocardial infarction, Internal medicine, Ventricle, Endocrinology, Cardiology, Ventricular remodeling